Venous hypertension affects veins in the legs and the way blood circulates to the heart. Learn about symptoms of venous ...

In pulmonary hypertension, a combination of metabolic and mechanical dysfunction leads to irreversible vascular damage.

Considerable variability exists in the clinical presentations of pulmonary arterial hypertension (PAH). Greater understanding of the comorbidities observed in Chinese patients with PAH is urgently ...

A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary ...

Mendelian randomization (MR) represents a valuable methodology to address the causal relationships between an exposure and an ...

Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...

A larger diameter of the main pulmonary artery predicts poorer outcomes in pulmonary arterial hypertension (PAH) patients, a study found.

Differences in clinical presentation, diagnosis, and treatment, and the potential effects on mortality, recurrent PE, and chronic thromboembolic pulmonary hypertension (CTEPH), are reviewed in the ...

Pathogenesis is the term that is used to describe the origin and development of a disease. Our study assessed the ability of existing influenza antivirals to treat severe A(H5N1) influenza in a ...

MetS, on the other hand, is a cluster of metabolic abnormalities, including central obesity, hypertension ... concentrations. The pathophysiology of OSA-associated dyslipidemia involves CIH ...

Hypertension is common and leads to negative outcomes ... cerebrovascular disease, dementia, chronic pulmonary disease, rheumatic disease, peptic ulcer disease, liver disease, mild, diabetes without ...